| Execution period | FY 2026-27 |
|---|
BSE filing, NSE: SANDUMA. Summary written from the filing by ALFA Finder's alert engine.
Sandur Manganese & Iron Ores Ltd: key numbers
- Share price
- ₹161.72
- Market cap
- ₹7,861 Cr
- Revenue (annual)
- ₹5,088 Cr
- Net profit (annual)
- ₹656.6 Cr
- P/E (TTM)
- 11.0×Sector 16.5×
- Promoter holding
- 74.22%+0.00% QoQ
- FII holding
- 1.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sandur Manganese & Iron Ores Ltd
All →Sandur Manganese & Iron Ores Board Meeting Date
Sandur Manganese & Iron Ores will hold a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window is closed from 1 October 2026 until 48 hours after the meeting.
Sandur Manganese & Iron Ores Capacity Expansion
SMIORE's subsidiary Royal Sandur MedTech leased 6.2 acres at AP MedTech Zone, Visakhapatnam for a medical devices manufacturing unit. This marks the company's entry into the medical devices segment.
- Execution
- 33-year lease tenure
- land for medical devices manufacturing unit
- 6.2 acres
Sandur Manganese & Iron Ores Other Announcement
Sandur Manganese & Iron Ores Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations.
Sandur Manganese & Iron Ores Merger & Restructuring Worth ₹1 Cr
The Sandur Manganese & Iron Ores Ltd incorporated a new wholly owned subsidiary, Royal Sandur MedTech Private Limited, for medical devices and consumables manufacturing.
- Value
- ₹1.00 Cr
Sandur Manganese & Iron Ores Merger & Restructuring Worth ₹1 Cr
Sandur Manganese & Iron Ores approved the incorporation of a wholly-owned subsidiary, 'Royal Sandur MedTech Private Limited', with a capital investment of ₹1 Crore.
- Value
- ₹1.00 Cr
Sandur Manganese & Iron Ores Legal & Regulatory
Sandur Manganese & Iron Ores Ltd's subsidiary, Royal Sandur Metals Private Limited, received a customs penalty order of ₹0.12 Crore.
- Value
- ₹0.12 Cr
Other management change announcements
All →NHPC Management Change
NHPC disclosed that Executive Director Shri Vivek Dwivedi's tenure ends on superannuation, effective October 31, 2026. The filing reports no replacement or financial impact.
BEML Management Change
BEML Limited informed exchanges that two senior executives, including the Executive Director (Offg.) Aparup Sinha, ceased office on superannuation effective 31 October 2026. No monetary value is involved.
Jay Jalaram Technologies Management Change
Jay Jalaram Technologies appointed Varjivandas Nathuram Thakkar as Non-Executive Non-Independent Director and Vishnu Harjivanbhai Thaker as Company Secretary. Both appointments are effective 31 October 2026.
Chennai Petroleum Corporation Management Change
Chennai Petroleum's Director (Operations) P. Kannan ceased on superannuation, effective 31 October 2026. S. G. Venkatesh takes additional charge from 1 November 2026.
GAMCO Management Change
GAMCO appointed Jayshri Tulsyan as Non-Executive Independent Director for 24 months, effective October 31, 2026. Ayushi Khaitan resigned as Non-Executive Non-Independent Director, citing personal reasons.
Dhampur Bio Organics Management Change
Dhampur Bio Organics' VP Financial Planning and Analysis, Harmeet Singh, resigned, effective October 31, 2026. It is a senior management departure.